For years, small-cap stocks haven’t lived up to their reputation for having high beta — especially when it comes to outperforming in boom times. That may be about to change, analysts say, as smaller companies look set to deliver faster earnings growth than their larger counterparts. Relatively cheap valuations may also touch off a wave of corporate deals that would also boost the group. Most Read from Bloomberg Profit for companies in the small- and mid-cap S&P 600 Index are on track to grow by 14% for ...

Valued at a market cap of $35.2 billion, Otis Worldwide Corporation (OTIS) is a global leader in manufacturing, installing, and servicing elevators, escalators, and moving walkways. The Farmington, Connecticut-based company's strong service portfolio, including maintenance and modernization offerings, generates stable recurring revenue, while continued investments in innovation and digitalization strengthen its market leadership. This industrial company has lagged behind the broader market over the past 5 ...

The Travelers Companies, Inc. (TRV) is a major American insurance provider, delivering property and casualty coverage for individuals, businesses, and organizations across the U.S. and select international markets. Its operations span personal insurance, business insurance, and specialty segments, with a focus on risk management and innovative solutions. The company is headquartered in New York City and is recognized for its broad range of insurance products and services. It has a market capitalization of ...

Atlanta, Georgia-based Rollins, Inc. (ROL) is a global leader in pest-control services, operating in more than 70 countries through a portfolio of wholly-owned subsidiaries and franchises. Valued at $28.4 billion by market cap, the company serves both residential and commercial clients, offering protection against termites, insects, rodents and wildlife. ROL has gained 15% over the past year, while the broader S&P 500 Index ($SPX) has rallied nearly 14.1%. In 2025, ROL stock is up 26.3%, surpassing the SP ...

Core Insights - Tencent Holdings Limited is a significant player in the technology and entertainment sectors, with quarterly earnings set to be released on November 13, 2025, and analysts estimating an EPS of $0.89 and revenue of approximately $26.57 billion [1] Financial Metrics - The company has a price-to-earnings (P/E) ratio of 26.11, indicating its market valuation, while the broader market shows significant earnings growth, with 91% of companies reporting so far and the S&P 500's EPS growth for Q3 2025 accelerating to 13.1% [2] - Tencent's price-to-sales ratio is 7.69, and its enterprise value to sales ratio is 8.02, reflecting its market valuation relative to revenue [2] Financial Health - The enterprise value to operating cash flow ratio stands at 19.94, and the earnings yield is 3.83%, indicating the company's ability to generate earnings and cash flow relative to its market valuation [3] - Tencent's debt-to-equity ratio is 0.37, suggesting a moderate level of debt that is manageable given its financial position [3] Liquidity and Stability - The current ratio of approximately 1.25 indicates the company's ability to cover short-term liabilities with short-term assets, which is crucial as it navigates a competitive landscape [4] - The financial metrics provide a comprehensive view of Tencent's market position and financial health, especially during a period marked by earnings results from recent IPOs like Gemini Space Station and Via Transportation [4]

Market Overview - The market correction appears to be over, with indicators shifting from optimistic to neutral, suggesting potential for continued growth into year-end driven by strong earnings [2][3] - The Nasdaq is currently down about 3% and remains less than 5% from its all-time highs, indicating that the market pullback is not significant [4] Earnings and Valuation - Earnings reports have been strong, with the S&P 500 trading at 23 times earnings, while the equal-weighted index is at 17 times, suggesting a balanced market [7] - Despite concerns, the underlying strength of the market remains robust, with expectations for high single-digit to double-digit equity market returns over the next 12 months [7] Investment Opportunities - Emerging markets and healthcare sectors are highlighted as attractive alternatives for investment, especially as healthcare begins to recover [8] - There are various investment avenues beyond the S&P 500, allowing investors to navigate potential market corrections [8] Speculation and Market Sentiment - Current market conditions do not exhibit significant speculative activity, as evidenced by put-call volume and investor sentiment surveys [9][10] - Foreign investment flows into the US remain strong, indicating confidence in the market [9] Historical Context - The current market cycle is compared to the late 1990s, with a notable difference being the presence of earnings backing current valuations, unlike the tech bubble era [10] - The capital spending boom is still in its early stages, suggesting further growth potential in the market [11]

Hey, we were talking about this earlier just kind of the shift in the momentum in the markets where investors seem to be turning away from the AI trade seemingly largely due to valuation concerns. Healthcare the best performing sector this week generally seen as a defensive sector. Just your take on that momentum shift.>> Yeah, I think it's to be expected a bit Frank. Um when you go into a cyclical recovery uh powered by both monetary and fiscal stimulus both of which we received in meaningful amounts this ...

Market Overview - The market is rallying on three key pillars: an easing Fed cycle, earnings growth, and strong economic conditions [2][4] - The Fed's easing cycle is perceived as somewhat shaky due to concerns about inflation and unemployment [4][19] Economic Conditions - The current economic environment is characterized by a K-shaped recovery, where different sectors are recovering at different rates [4][15] - There are concerns regarding the credit market and potential fiscal implications due to increased activity in the repo market [7][8] Earnings Growth - Strong earnings growth is crucial for market performance, with companies showing broadening earnings potential [6][22] - The impact of artificial intelligence on productivity is noted, with companies able to do more with fewer employees, raising concerns about consumer demand [10][13][15] Federal Reserve Outlook - There is uncertainty regarding the Fed's path forward, particularly for a potential rate cut in December, as economic data remains unclear [19][20] - Corporate earnings are expected to provide insights into consumer behavior, especially concerning lower-income consumers [22][23]

With a market cap of $218.8 billion, Abbott Laboratories (ABT) is a global healthcare leader with a diversified portfolio spanning medical devices, diagnostics, nutrition, and branded generic pharmaceuticals. The North Chicago, Illinois-based company is best known for innovations like its FreeStyle Libre glucose monitoring system. Abbott plays a major role in chronic disease management, lab testing technologies, and specialized nutrition with brands such as Ensure, Pedialyte, and Similac. Over the past ye ...

Of the group’s results we have seen already, the market loved the numbers from Amazon (AMZN) and Alphabet (GOOGL), didn’t like what it saw from Microsoft (MSFT) and Meta (META), Apple (AAPL) and Tesla (TSLA) results fall somewhere in the middle.The expectation is that Nvidia will come out with $1.23 per share in earnings on $54.59 billion in revenues, representing year-over-year growth rates of +51.9% and +55.6%, respectively. Estimates have largely been stable over the last two months, but they are up rela ...